Meng-yao Lu
No. 1, Changde Street
TPQ 10048, Taiwan
TPQ 10048, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 89 publications
Postoperative [18F]FDOPA and [18F]FDG PET Semiquantitative Scoring System for Risk Stratification in Neuroblastoma: A Three-tier Classification Approach.
Journal: Clinical nuclear medicine
Published: May 26, 2026
Letermovir for cytomegalovirus prophylaxis in pediatric allogeneic hematopoietic stem cell transplantation: a single-center experience.
Journal: Blood research
Published: December 25, 2025
Ruxolitinib in treatment-naive or corticosteroid-refractory pediatric patients with chronic graft-versus-host disease: final analysis of the phase II REACH5 trial.
Journal: Haematologica
Published: October 31, 2025
Low flow cytometry events in detecting CNS involvement in pediatric B-cell precursor ALL: NGS validation and prognostic significance.
Journal: Blood advances
Published: September 05, 2025
Genetic landscape of pediatric acute myeloid leukemia in Taiwan.
Journal: Scientific reports
Published: August 13, 2025
Impact of SNP Variants in PON-1 or UGT1A1 on Iron Chelation Therapy Outcomes and Zinc Status in Thalassemia Major Patients.
Journal: Biological trace element research
Published: May 09, 2025
[68Ga]Ga-DOTA-TOC positron emission tomography outperforms [18F]FDOPA and [18F]FDG PET in pediatric neuroblastoma imaging: a prospective study.
Journal: European journal of nuclear medicine and molecular imaging
Published: April 29, 2025
Preemptive NUDT15 Genotyping and Its Impact on Febrile Neutropenia in Pediatric Patients With Acute Lymphoblastic Leukemia in Taiwan.
Journal: Journal of pediatric hematology/oncology
Published: March 17, 2025
Ruxolitinib for pediatric acute and chronic graft-versus-host disease: a single-center retrospective study of efficacy and safety.
Journal: Annals of hematology
Published: October 30, 2024
Disease burden, management strategies, and unmet needs in α-thalassemia due to hemoglobin H disease.
Disease burden, management strategies, and unmet needs in α-thalassemia due to hemoglobin H disease.
Journal: American journal of hematology
Published: April 04, 2024
Ruxolitinib in treatment-naive or corticosteroid-refractory paediatric patients with chronic graft-versus-host disease (REACH5): interim analysis of a single-arm, multicentre, phase 2 study.
Journal: The Lancet. Haematology
Published: January 30, 2024
Last Updated: 09/26/2026